Mcf Advisors LLC Neogenomics Inc Transaction History
Mcf Advisors LLC
- $1.42 Billion
- Q4 2024
A detailed history of Mcf Advisors LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Mcf Advisors LLC holds 363 shares of NEO stock, worth $4,029. This represents 0.0% of its overall portfolio holdings.
Number of Shares
363
Previous 363
-0.0%
Holding current value
$4,029
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$218 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$158 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$72.5 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$68.4 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$68.3 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.4B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...